Bethesda Thyroid Cytopathology Classification System: Standardizing Diagnosis And Enhancing Patient Outcomes
Developed in 2007, the Bethesda Classification System categorizes thyroid cytopathology into six classes, ranging from normal (I) to malignant (VI). It standardizes reporting to ensure consistent diagnosis, risk assessment, and clinical management of thyroid lesions. The system helps identify benign and malignant lesions and guides appropriate follow-up or intervention for intermediate-risk cases (III-IV), contributing to …